Authors: Linden, PK Moellering, RC Wood, CA Rehm, SJ Flaherty, J Bompart, F Talbot, GH

Citation: Pk. Linden et al., Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin, CLIN INF D, 33(11), 2001, pp. 1816-1823

Authors: Linden, PK Bompart, F Gray, S Talbot, GH

Citation: Pk. Linden et al., Hyperbilirubinemia during quinupristin-dalfopristin therapy in liver transplant recipients: Correlation with available liver biopsy results, PHARMACOTHE, 21(6), 2001, pp. 661-668

Authors: Moellering, RC Linden, PK Reinhardt, J Blumberg, EA Bompart, F Talbot, GH

Citation: Rc. Moellering et al., The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium (Reprinted from The Journal Antimicrobial Chemotherapy, vol 44, pg 251-261, 1999), FORMULARY, 35, 2000, pp. S25-S35

Authors: Raad, I Bompart, F Hachem, R

Citation: I. Raad et al., Prospective, randomized dose-ranging open phase II pilot study of quinupristin dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia, EUR J CL M, 18(3), 1999, pp. 199-202

Authors: Moellering, RC Linden, PK Reinhardt, J Blumberg, EA Bompart, F Talbot, GH

Citation: Rc. Moellering et al., The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium, J ANTIMICRO, 44(2), 1999, pp. 251-261